Study identifies genetic mutations that contr

Epilepsy affects approximately 1-in-26 people and the most common form, known as temporal lobe epilepsy (TLE), often cannot be adequately treated with anti-seizure medications. Patients with this form of epilepsy may require neurosurgery to provide relief from seizures.

Related Keywords

Massachusetts ,United States ,Australia ,Boston ,American ,Kristopher Kahle ,Christopher Walsh ,Nicholast Zervas ,Sattar Khoshkhoo ,National Institutes Of Neurological Disease ,Department Of Neurology At Brigham ,Disease Research At Boston Children Hospital ,Manton Center ,Simons Foundation ,Method Of Research ,Howard Hughes Medical Institute ,Hydrocephalus Association ,Allen Discovery Center ,Rudi Schulte Research Institute ,Research Council Ideas Grant ,National Institutes Of Health ,Research Council Investigator Grant ,Suh Kyungbae Foundation ,Innovation Programme Marie Sklodowska Curie Actions Individual Fellowship ,Research Council Project ,Harvard Medical School ,Templeton Foundation ,Yale Rockefeller Centers For Mendelian Genomics ,Allen Frontiers Group Foundation ,Australia National Health ,Allen Frontiers Program ,European Commission Horizon ,Journal Of The American Medical Association ,Mass General Brigham ,Boston Children ,Endowed Chair ,Pediatric Neurosurgery ,Massachusetts General Hospital ,Mass General ,National Institutes ,Neurological Disease ,Allen Frontiers ,Gallen Foundation ,Doris Duke Physician Scientist Fellowship ,Orphan Disease Research ,European Commission ,Medical Research Council Investigator ,Medical Research Council Ideas ,Medical Research Council Project ,Yale Rockefeller Centers ,Mendelian Genomics ,Rudi Schulte Research ,Mitogen Activated Protein Kinase Variants ,Drug Resistant Mesial Temporal Lobe ,American Medical ,